Financials
- Market Capitalization 113.26 M
- Employee 130
- Founded 2016
- CEO N/A
- Website www.nautilus.bio
- Headquarter Washington, United States
- FIGI BBG00W7G4M12
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-4.15
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3870 | ANIX Anixa Biosciences, Inc. - Common Stock | 3.48 USD | -3.33% | -4.92% | 0.00% | +17.57% | 118.40 M USD | ||
| 3874 | RANI Rani Therapeutics Holdings, Inc. - Class A Common Stock | 0.84 USD | -1.18% | -5.62% | -1.18% | +68.00% | 117.09 M USD | ||
| 3897 | ONCY Oncolytics Biotech Inc. - Common Stock | 0.86 USD | +1.18% | +2.38% | +13.16% | -17.31% | 109.66 M USD | ||
| 3898 | SEER Seer, Inc. - Class A Common Stock | 1.98 USD | -1.49% | -3.88% | -4.35% | -3.41% | 109.64 M USD |